Globus Medical, Inc.
GMED
$91.70
-$2.10-2.24%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 25.73% | 22.91% | 18.37% | -1.41% | 6.61% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 25.73% | 22.91% | 18.37% | -1.41% | 6.61% |
| Cost of Revenue | 17.82% | -9.00% | -6.64% | 4.09% | 1.51% |
| Gross Profit | 29.61% | 47.21% | 35.96% | -3.87% | 9.30% |
| SG&A Expenses | 20.58% | 18.50% | 26.76% | -1.12% | 3.29% |
| Depreciation & Amortization | -1.85% | -0.77% | 1.62% | -2.95% | 6.36% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 17.44% | 4.01% | 8.71% | -3.62% | -1.09% |
| Operating Income | 60.99% | 238.07% | 105.47% | 11.60% | 59.34% |
| Income Before Tax | 586.07% | 152.48% | 295.48% | 1,311.36% | -1.31% |
| Income Tax Expenses | 1,658.16% | 381.68% | -192.74% | 2,057.39% | -118.45% |
| Earnings from Continuing Operations | 430.44% | 129.50% | 538.68% | 1,160.31% | 76.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 430.44% | 129.50% | 538.68% | 1,160.31% | 76.30% |
| EBIT | 60.99% | 238.07% | 105.47% | 11.60% | 59.34% |
| EBITDA | 40.64% | 105.68% | 57.78% | 14.61% | 28.39% |
| EPS Basic | 439.45% | 131.42% | 538.70% | 1,149.05% | 77.89% |
| Normalized Basic EPS | 125.20% | 194.49% | 114.83% | 44.64% | -3.26% |
| EPS Diluted | 436.89% | 131.58% | 547.83% | 1,126.62% | 82.87% |
| Normalized Diluted EPS | 126.50% | 197.77% | 115.60% | 41.52% | -4.57% |
| Average Basic Shares Outstanding | -1.70% | -0.82% | 0.01% | 1.03% | -0.84% |
| Average Diluted Shares Outstanding | -2.25% | -1.93% | -0.35% | 3.26% | 0.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |